Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival.

Zhang J, Caruso FP, Sa JK, Justesen S, Nam DH, Sims P, Ceccarelli M, Lasorella A, Iavarone A.

Commun Biol. 2019 Apr 23;2:135. doi: 10.1038/s42003-019-0369-7. eCollection 2019.

2.

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.

Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA Jr, Brahmer JR, Pardoll DM, Anders RA, Housseau F.

J Immunother Cancer. 2019 Mar 6;7(1):63. doi: 10.1186/s40425-019-0547-7.

3.

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.

Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA Jr, Brahmer JR, Pardoll DM, Anders RA, Housseau F.

J Immunother Cancer. 2019 Feb 11;7(1):40. doi: 10.1186/s40425-018-0492-x. Erratum in: J Immunother Cancer. 2019 Mar 6;7(1):63.

4.

Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.

Thanki K, Zeng X, Justesen S, Tejlmann S, Falkenberg E, Van Driessche E, Mørck Nielsen H, Franzyk H, Foged C.

Eur J Pharm Biopharm. 2017 Nov;120:22-33. doi: 10.1016/j.ejpb.2017.07.014. Epub 2017 Jul 26.

PMID:
28756280
5.

Adjuvants Based on Synthetic Mycobacterial Cord Factor Analogues: Biophysical Properties of Neat Glycolipids and Nanoself-Assemblies with DDA.

Kallerup RS, Franzyk H, Schiøth ML, Justesen S, Martin-Bertelsen B, Rose F, Madsen CM, Christensen D, Korsholm KS, Yaghmur A, Foged C.

Mol Pharm. 2017 Jul 3;14(7):2294-2306. doi: 10.1021/acs.molpharmaceut.7b00170. Epub 2017 May 31.

PMID:
28497975
6.

Conserved Molecular Superlattices in a Series of Homologous Synthetic Mycobacterial Cell-Wall Lipids Forming Interdigitated Bilayers.

Martin-Bertelsen B, Yaghmur A, Franzyk H, Justesen S, Kirkensgaard JJ, Foged C.

Langmuir. 2016 Dec 6;32(48):12693-12701. Epub 2016 Nov 22.

PMID:
27934510
7.

Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity.

Hong E, Usiskin IM, Bergamaschi C, Hanlon DJ, Edelson RL, Justesen S, Pavlakis GN, Flavell RA, Fahmy TM.

J Biol Chem. 2016 Apr 22;291(17):8931-50. doi: 10.1074/jbc.M115.695304. Epub 2015 Dec 30.

8.

Materno-Fetal Transfer of Preproinsulin Through the Neonatal Fc Receptor Prevents Autoimmune Diabetes.

Culina S, Gupta N, Boisgard R, Afonso G, Gagnerault MC, Dimitrov J, Østerbye T, Justesen S, Luce S, Attias M, Kyewski B, Buus S, Wong FS, Lacroix-Desmazes S, Mallone R.

Diabetes. 2015 Oct;64(10):3532-42. doi: 10.2337/db15-0024. Epub 2015 Apr 27.

9.

Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance.

Gupta N, Culina S, Meslier Y, Dimitrov J, Arnoult C, Delignat S, Gangadharan B, Lecerf M, Justesen S, Gouilleux-Gruart V, Salomon BL, Scott DW, Kaveri SV, Mallone R, Lacroix-Desmazes S.

Sci Transl Med. 2015 Feb 18;7(275):275ra21. doi: 10.1126/scitranslmed.aaa1957.

PMID:
25696000
10.

A carbon nanotube-polymer composite for T-cell therapy.

Fadel TR, Sharp FA, Vudattu N, Ragheb R, Garyu J, Kim D, Hong E, Li N, Haller GL, Pfefferle LD, Justesen S, Herold KC, Fahmy TM.

Nat Nanotechnol. 2014 Aug;9(8):639-47. doi: 10.1038/nnano.2014.154. Epub 2014 Aug 3. Erratum in: Nat Nanotechnol. 2014 Sep;9(9):723. Harold, Kevin C [corrected to Herold, Kevan C].

PMID:
25086604
11.

Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.

Braendstrup P, Mortensen BK, Justesen S, Osterby T, Rasmussen M, Hansen AM, Christiansen CB, Hansen MB, Nielsen M, Vindeløv L, Buus S, Stryhn A.

PLoS One. 2014 Apr 23;9(4):e94892. doi: 10.1371/journal.pone.0094892. eCollection 2014.

12.

MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.

Braendstrup P, Justesen S, Osterbye T, Nielsen LL, Mallone R, Vindeløv L, Stryhn A, Buus S.

PLoS One. 2013 Sep 2;8(9):e73648. doi: 10.1371/journal.pone.0073648. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/9375e7cb-92f1-4a83-adaf-c11f284ceee0. PLoS One. 2013;8(9). doi:10.1371/annotation/97cabee9-2a2a-4bd6-a417-a2075e56a8d4.

13.

Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display.

Gunnarsen KS, Kristinsson SG, Justesen S, Frigstad T, Buus S, Bogen B, Sandlie I, Løset GÅ.

Sci Rep. 2013;3:1162. doi: 10.1038/srep01162. Epub 2013 Jan 29.

14.

Adsorption of multimeric T cell antigens on carbon nanotubes: effect on protein structure and antigen-specific T cell stimulation.

Fadel TR, Li N, Shah S, Look M, Pfefferle LD, Haller GL, Justesen S, Wilson CJ, Fahmy TM.

Small. 2013 Mar 11;9(5):666-72. doi: 10.1002/smll.201201684. Epub 2012 Oct 23.

PMID:
23090793
15.

Wildtype p53-specific antibody and T-cell responses in cancer patients.

Pedersen AE, Stryhn A, Justesen S, Harndahl M, Rasmussen S, Donskov F, Claesson MH, Pedersen JW, Wandall HH, Svane IM, Buus S.

J Immunother. 2011 Nov-Dec;34(9):629-40. doi: 10.1097/CJI.0b013e3182281381.

PMID:
21989411
16.

Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.

Wang M, Tang ST, Stryhn A, Justesen S, Larsen MV, Dziegiel MH, Lewinsohn DM, Buus S, Lund O, Claesson MH.

Immunology. 2011 Apr;132(4):482-91. doi: 10.1111/j.1365-2567.2010.03383.x. Epub 2011 Feb 7.

17.

NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure.

Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S.

Immunome Res. 2010 Nov 13;6:9. doi: 10.1186/1745-7580-6-9.

18.

HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.

Wang M, Larsen MV, Nielsen M, Harndahl M, Justesen S, Dziegiel MH, Buus S, Tang ST, Lund O, Claesson MH.

PLoS One. 2010 May 7;5(5):e10533. doi: 10.1371/journal.pone.0010533.

19.

Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.

Justesen S, Harndahl M, Lamberth K, Nielsen LL, Buus S.

Immunome Res. 2009 May 5;5:2. doi: 10.1186/1745-7580-5-2.

20.

Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target protein.

Justesen SF, Lamberth K, Nielsen LL, Schafer-Nielsen C, Buus S.

Protein Sci. 2009 May;18(5):1023-32. doi: 10.1002/pro.112.

21.

Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.

Harndahl M, Justesen S, Lamberth K, Røder G, Nielsen M, Buus S.

J Biomol Screen. 2009 Feb;14(2):173-80. doi: 10.1177/1087057108329453. Epub 2009 Feb 4.

PMID:
19196700
22.

Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues.

Andersen JT, Justesen S, Fleckenstein B, Michaelsen TE, Berntzen G, Kenanova VE, Daba MB, Lauvrak V, Buus S, Sandlie I.

FEBS J. 2008 Aug;275(16):4097-110. doi: 10.1111/j.1742-4658.2008.06551.x. Epub 2008 Jul 15.

23.

Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.

Nielsen M, Lundegaard C, Blicher T, Peters B, Sette A, Justesen S, Buus S, Lund O.

PLoS Comput Biol. 2008 Jul 4;4(7):e1000107. doi: 10.1371/journal.pcbi.1000107.

24.

One-pot, mix-and-read peptide-MHC tetramers.

Leisner C, Loeth N, Lamberth K, Justesen S, Sylvester-Hvid C, Schmidt EG, Claesson M, Buus S, Stryhn A.

PLoS One. 2008 Feb 27;3(2):e1678. doi: 10.1371/journal.pone.0001678.

25.

A strategy for bacterial production of a soluble functional human neonatal Fc receptor.

Andersen JT, Justesen S, Berntzen G, Michaelsen TE, Lauvrak V, Fleckenstein B, Buus S, Sandlie I.

J Immunol Methods. 2008 Feb 29;331(1-2):39-49. Epub 2007 Dec 10.

PMID:
18155020
26.

NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence.

Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, Røder G, Peters B, Sette A, Lund O, Buus S.

PLoS One. 2007 Aug 29;2(8):e796.

28.

Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.

Røder G, Blicher T, Justesen S, Johannesen B, Kristensen O, Kastrup J, Buus S, Gajhede M.

Acta Crystallogr D Biol Crystallogr. 2006 Nov;62(Pt 11):1300-10. Epub 2006 Oct 18.

PMID:
17057332
29.

Fractionation, solid-phase immobilization and chemical degradation of long pectin oligogalacturonides. Initial steps towards sequencing of oligosaccharides.

Guillaumie F, Justesen SF, Mutenda KE, Roepstorff P, Jensen KJ, Thomas OR.

Carbohydr Res. 2006 Jan 16;341(1):118-29. Epub 2005 Nov 17.

PMID:
16297890
30.

Fractionation of whey proteins with high-capacity superparamagnetic ion-exchangers.

Heebøll-Nielsen A, Justesen SF, Thomas OR.

J Biotechnol. 2004 Sep 30;113(1-3):247-62.

PMID:
15380659
31.

SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation.

Sylvester-Hvid C, Nielsen M, Lamberth K, Røder G, Justesen S, Lundegaard C, Worning P, Thomadsen H, Lund O, Brunak S, Buus S.

Tissue Antigens. 2004 May;63(5):395-400.

PMID:
15104671
32.

Definition of supertypes for HLA molecules using clustering of specificity matrices.

Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, Worning P, Sylvester-Hvid C, Lamberth K, Røder G, Justesen S, Buus S, Brunak S.

Immunogenetics. 2004 Mar;55(12):797-810. Epub 2004 Feb 13.

PMID:
14963618
33.

Purification and characterization of osteopontin from human milk.

Sørensen S, Justesen SJ, Johnsen AH.

Protein Expr Purif. 2003 Aug;30(2):238-45.

PMID:
12880773
34.

Slowing the spread of gonorrhea.

Justesen S.

Nursing. 2002 Apr;32(4):22. No abstract available.

PMID:
11969006
35.

Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.

Sørensen S, Justesen SJ, Johnsen AH.

Urol Res. 1995;23(5):327-34.

PMID:
8839390
36.

An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.

Sørensen S, Hansen K, Bak S, Justesen SJ.

Urol Res. 1990;18(6):373-9.

PMID:
2100411

Supplemental Content

Loading ...
Support Center